全人源单克隆抗体/双特异性抗体 – 原能细胞科技集团

Based on our own large human phage antibody library, we focus on the joint development and clinical transformation of human monoclonal antibodies, bispecific antibodies used for biopharmaceuticals and cell therapy。

➨ Joint development of antibody candidate drugs

➨ Research and development of monoclonal antibodies

➨ Research and development of bispecific antibody

全人源单克隆抗体/双特异性抗体 – 原能细胞科技集团

Based on our own large human phage antibody library, we focus on the joint development and clinical transformation of human monoclonal antibodies, bispecific antibodies used for biopharmaceuticals and cell therapy。

➨ Joint development of antibody candidate drugs

➨ Research and development of monoclonal antibodies

➨ Research and development of bispecific antibody

Technology

Therapy Area

Development Progress

PD-L1

Human Monoclonal Antibody

Cancer

Preclinical

IL-17

Human Monoclonal Antibody

Autoimmune Disease

Preclinical

4-1BB

Human Monoclonal Antibody

Cancer

Preclinical

PD-L1/4-1BB

Bispecific Antibody

Cancer

Preclinical

GPC3/CD3

Bispecific Antibody

Cancer

L-Opt

4-1BB/GPC3

Bispecific Antibody

Cancer

L-Opt

EpCAM/CD3

Bispecific Antibody

Cancer

L-Opt